Overview


According to Futurewise analysis, the Global Repairing Chordae Tendineae (CT) market is estimated to grow 1.68x between 2024 and 2032, creating an absolute opportunity of more than USD 234 million. The growth trajectory of the market indicates a rising prevalence of mitral valve disorders and an increased adoption of minimally invasive cardiac surgical techniques globally. This market expansion is further fueled by technological advancements in artificial chordae materials and surgical instruments, as well as a growing awareness of the benefits of early intervention for patients with chordae tendineae rupture. Additionally, the aging global population and improvements in healthcare infrastructure in emerging markets are expected to significantly boost the sustained demand for chordae tendineae (CT) repair procedures during the forecast period.

The artificial chordae market was valued at USD 500 million in 2024 and is projected to grow significantly, reaching an estimated USD 1.2 billion by 2035. This growth represents a compound annual growth rate (CAGR) of approximately 9.1%. Major companies in this sector include Abbott, Edwards Lifesciences, CryoLife, and Medtronic, indicating a competitive landscape focused on advancing technologies in heart valve repair and replacement.  Repairing Chordae Tendineae (CT) market is expected to grow with the increasing prevalence of mitral valve diseases and advancements in minimally invasive cardiac surgeries. Additionally, the rising elderly population, prone to degenerative heart conditions, is further boosting demand for chordae tendineae repair procedures.

Researchers are developing dynamic valve simulations tailored to individual patients by utilizing 3D-printed models to assess repair strategies. This approach is essential for repairing pediatric atrioventricular valves. In a case series focused on surgical repair for mitral valve prolapse caused by elongated papillary muscles, pre-measured artificial chordae were used, providing a precise technical refinement in traditional surgical procedures.

FutureWise Market Research has released a report providing an in-depth analysis of Repairing Chordae Tendineae (CT) Market trends that will impact overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Repairing Chordae Tendineae (CT) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Gore Medical
  • NeoChord, Inc.
  • Medtronic
  • Abbott Laboratories
  • Edwards Lifesciences
  • Aesculap AG
  • Fehling Surgical Instruments, Inc.
  • LivaNova (formerly Sorin Group)
  • Lepu Medical Technology Co ltd.
  • Terumo Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Repairing Chordae Tendineae (CT) Market:

NeoChord, Inc.

  • Received FDA Investigational Device Exemption (IDE) to initiate a pivotal clinical trial of their artificial chordae delivery system across 20 mitral repair centers in the U.S.
  • The NeoChord DS1000 is a transapical system designed for beating-heart procedures, and it has been gaining attention in clinical forums and registries, targeting broader adoption in Europe and the U.S.

Abbott Laboratories

  • In June 2025, Abbott Laboratories partnered with CryoLife to collaboratively develop technologies for artificial chordae replacement.
  • Edwards Lifesciences (February 2025) has acquired ChordArt Medical, enhancing its artificial chordae platform.

LivaNova (formerly Sorin Group)

  • LivaNova is actively developing and promoting the Memo 3D ReChord annuloplasty ring, which features a chordal guiding system designed to simplify the surgical process of chordal replacement. This technology continues to be a central component of their structural heart portfolio. However, there have been no recent public updates regarding advancements or new approvals in chordal repair for the years 2024–2025.

By Product Type

  • Biological Grafts
  • Artificial Chordae Tendineae
  • Forceps
  • Heart Lung Machine
  • Others

By Patient Demographic

  • Pediatric
  • Adult
  • Geriatric

By Technology

  • Invasive Procedures
  • Minimally-Invasive Procedures

By End-User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers (ASCs)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Geographically, the Repairing Chordae Tendineae (CT) market is expected to see significant growth in North America, driven by advanced healthcare infrastructure and increasing cardiovascular cases. At the same time, the Asia-Pacific region is anticipated to grow rapidly due to rising healthcare awareness, improved medical access, and a growing aging population.  Asia Pacific is expected to register the highest CAGR of 7.4% during the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Repairing Chordae Tendineae (CT) Market by By Product Type, By Patient Demographic, By Technology, By End-User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Repairing Chordae Tendineae (CT) Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Repairing Chordae Tendineae (CT) Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Repairing Chordae Tendineae (CT) Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Repairing Chordae Tendineae (CT) Market, By Product Type Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Biological Grafts
        2. Artificial Chordae Tendineae
        3. Forceps
        4. Heart Lung Machine
        5. Others

  • 8.  Repairing Chordae Tendineae (CT) Market, By Patient Demographic Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Pediatric
        2. Adult
        3. Geriatric

  • 9.  Repairing Chordae Tendineae (CT) Market, By Technology Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Invasive Procedures
        2. Minimally-Invasive Procedures

  • 10.  Repairing Chordae Tendineae (CT) Market, By End-User Historical Analysis and Forecast 2025-2033 (USD Million)
    •   1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers (ASCs)

  • 11.  North America Repairing Chordae Tendineae (CT) Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2025-2033

  • 12.  Latin America Repairing Chordae Tendineae (CT) Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2025-2033

  • 13.  Europe Repairing Chordae Tendineae (CT) Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2025-2033

  • 14.  Asia Pacific Repairing Chordae Tendineae (CT) Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2025-2033

  • 15.  Middle East and Africa Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2025-2033

  • 16.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •        1. Gore Medical
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. NeoChord, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Medtronic
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Abbott Laboratories
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Edwards Lifesciences
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Aesculap AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Fehling Surgical Instruments, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. LivaNova (formerly Sorin Group)
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Lepu Medical Technology Co ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
          10. Terumo Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.  Pre and Post COVID-19 Impact
    •        1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.  FutureWise SME Key Takeaway Points for Client
    •   

FAQ


Chordae tendineae (often called “heart strings”) are fibrous cords that connect the mitral and tricuspid valve leaflets to the papillary muscles of the heart.
They prevent valve prolapse during ventricular contraction and are essential for proper valve function.

  • Technical complexity: Precise chord length and tensioning are critical.
  • Durability concerns: Artificial chordae must withstand lifelong cardiac stresses.
  • Regulatory hurdles: Transcatheter systems face stringent safety requirements.
  • Training needs: Surgeons require advanced skills and imaging support for minimally invasive repairs.
  • Competition from valve replacement: In some cases, replacement is still the default option.
  • Shift toward transcatheter and minimally invasive devices (ChordArt, LifeCord, NeoChord).
  • Growth in simulation and AI planning tools for customized repair strategies.
  • Material science innovations (ePTFE + UHMWPE, biohybrids, thrombo-resistant coatings).
  • Convergence of robotics and imaging to enhance procedural accuracy.
  • Strategic partnerships and acquisitions by larger medtech firms consolidating the space.

Related Market

Dual and Multi-Energy Computed Tomography (CT) Market

Read More

Solid Organ Transplantation Rejection (SOT) Market

Read More

Anti-body Coupled T Receptor Therapy Market

Read More
Partner

Our Clients